Remission, prediction and stability of symptoms in schizophrenia: A naturalistic 12-month follow-up study

References

• Andreasen NC, Carpenter WT Jr, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005;162:441–9.
   PubMed Web of Science ®Google Scholar
• Breier A, Schreiber JL, Dyer J, Pickar D. National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome in schizophrenia. Arch Gen Psychiatry 1991;48:239–46.
   PubMed Web of Science ®Google Scholar
• Carpenter WT Jr, Strauss JS. The prediction of outcome in schizophrenia IV: eleven-year follow-up of the Washington IPSS Cohort. J Nerv Ment Dis 1991;179:517–25.
   PubMed Web of Science ®Google Scholar
• Harding CM, Brooks GW, Ashikaga T, Straus JS, Breier A. The Vermont longitudinal study of persons with severe mental illness, II: long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. Am J Psychiatry 1987;144:727–35.
   PubMed Web of Science ®Google Scholar
• Harrison G, Croudace T, Mason P, Glazebrook C, Medley I. Predicting the long-term outcome of schizophrenia. Psychol Med 1996;26:697–705.
   PubMed Web of Science ®Google Scholar
• Harrison G, Hopper K, Craig T, Laska E, Siegel C, Wanderling J, . Recovery from psychotic illness: a 15- and 25-year international follow-up study. Br J Psychiatry 2001;178:506–17.
   PubMed Web of Science ®Google Scholar
• Buckley PF, Harvey PD, Bowie CR, Loebel A. The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone. Schizophr Res 2007;94:99–106.
   PubMed Web of Science ®Google Scholar
• De Hert M, van Winkel R, Wampers M, Kane J, van Os J, Peuskens J. Remission criteria for schizophrenia: evaluation in a large naturalistic cohort. Schizophr Res 2007;92:68–73.
   PubMed Web of Science ®Google Scholar
• Docherty JP, Bossie CA, Lachaux B, Bouhours P, Zhu Y, Lasser R, . Patient-based and clinician-based support for the remission criteria in schizophrenia. Int Clin Psychopharmacol 2007;22:51–5.
   PubMed Web of Science ®Google Scholar
• Dunayevich E, Sethuraman G, Enerson M, Taylor CC, Lin D. Characteristics of two alternative schizophrenia remission definitions: relationship to clinical and quality of life outcomes. Schizophr Res 2006;86:300–8.
   PubMed Web of Science ®Google Scholar
• Emsley R, Rabinowitz J, Medori R. Remission in early psychosis: rates, predictors, and clinical and functional outcome correlates. Schizophr Res 2007;89:129–39.
   PubMed Web of Science ®Google Scholar
• Haro JM, Novick D, Suarez D, Alonso J, Lépine JP, Ratcliffe M. Remission and relapse in the outpatient care of schizophrenia – three-year results from the Schizophrenia Outpatient Health Outcomes Study. J Clin Psychopharmacol 2006;26:571–8.
   PubMed Web of Science ®Google Scholar
• Helldin L, Kane JM, Karilampi U, Norlander T, Archer T. Remission and cognitive ability in a cohort of patients with schizophrenia. J Psychiatr Res 2006;40:738–45.
   PubMed Web of Science ®Google Scholar
• Jäger M, Riedel M, Schmauss M, Laux G, Pfeiffer H, Naber D, . Prediction of symptom remission in schizophrenia during inpatient treatment. World J Biol Psychiatry 2007;8:1–9.
   Google Scholar
• Kane JM, Crandall DT, Marcus RN, Eudicone J, Pikalov A, Carson WH, . Symptomatic remission in schizophrenia patients treated with aripiprazole or haloperidol for up to 52 weeks. Schizophr Res 2007;95:143–150.
   PubMed Web of Science ®Google Scholar
• Kelly DL, Weiner E, Ball MP, McMahon RP, Carpenter WT, Buchanan RW. Remission in schizophrenia: The relationship to baseline symptoms and changes in symptom domains during a one-year study. J Psychopharmacol 2009;23:436–441. doi:10.1177/0269881108093883.
   PubMed Web of Science ®Google Scholar
• Lambert M, Schimmelmann BG, Naber D, Schacht A, Karow A, Wagner T, . Prediction of remission as a combination of symptomatic remission and adequate subjective well-being in 2960 patients with schizophrenia. J Clin Psychiatry 2006;67:1690–7.
   PubMed Web of Science ®Google Scholar
• Leucht S, Beitinger R, Kissling W. On the concept of remission in schizophrenia. Psychopharmacology 2007; 194:453–61.
   Google Scholar
• Novick D, Haro JM, Suarez D, Lambert M, Lépine JP, Naber D. Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study. Psychopharmacology 2007;191:1015–22.
   PubMedGoogle Scholar
• Opler MG, Yang LH, Caleo S, Alberti P. Statistical validation of the criteria for symptom remission in schizophrenia: preliminary findings. BMC Psychiatry 2007;7:35.
   PubMed Web of Science ®Google Scholar
• San L, Ciudad A, Alvarez E, Bobes J, Gilaberte I. Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional study. Eur Psychiatry 2007;22:490–8.
   PubMed Web of Science ®Google Scholar
• Van Os J, Drukker M, à Campo J, Meijer J, Bak M, Delespaul P. Validation of remission criteria for schizophrenia. Am J Psychiatry 2006;163:2000–2.
   PubMed Web of Science ®Google Scholar
• Wunderink L, Sytema S, Nienhuis FJ, Wiersma D. Clinical recovery in first-episode psychosis. Schizophr Bull 2008. doi:10.1093/schbul/sbn143.
   Google Scholar
• Haro JM, Edgell ET, Jones PB, Alonso J, Gavart S, Gregor KJ, . The European Schizophrenia Outpatient Health Outcomes (SOHO) study: rationale, methods and recruitment. Acta Psychiatr Scand 2003;107:222–32.
   PubMed Web of Science ®Google Scholar
• Bachmann S, Bottmer C, Schröder J. One-year outcome and its prediction in first-episode schizophrenia – a naturalistic study. Psychopathology 2008;41:115–23.
   Google Scholar
• Gupta S, Andreasen NC, Arndt S, Flaum M, Hubbard WC, Ziebell S. The Iowa longitudinal Study of Recent Onset Psychosis: one-year follow-up of first episode patients. Schizophr Res 1997;23:1–13.
   PubMed Web of Science ®Google Scholar
• Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962;10:799–812.
   Web of Science ®Google Scholar
• Kay SR, Opler LA, Lindenmayer JP. The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. Br J Psychiatry 1989;7:S59–67.
   Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th. Washington, DC: American Psychiatric Press; 1996.
   Google Scholar
• Tegeler D, Juckel G. Validierung der Personal and Social Performance Scale (PSP) an einer Stichprobe akut schizophrener Patienten. Nervenarzt 2007;78:S74.
   Google Scholar
• Naber D, Moritz S, Lambert M, Rajonk F, Holzbach R, Mass R, . Improvement of schizophrenic patients’ subjective well-being under atypical antipsychotic drugs. Schizophr Res 2001;50:79–88.
   PubMed Web of Science ®Google Scholar
• Curtis CE, Calkins ME, Grove WM, Feil KJ, Iacono WG. Saccadic disinhibition in patients with acute and remitted schizophrenia and their first-degree biological relatives. J Clin Psychiatry 2001;8:100–6.
   Google Scholar
• Harding CM, Brooks GW, Ashikaga T, Straus JS, Breier A. The Vermont longitudinal study of persons with severe mental illness, II: Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. Am J Psychiatry 1987;144:727–35.
   PubMed Web of Science ®Google Scholar
• Lambert M, Naber D, Eich FX, Schacht M, Linden M, Schimmelmann BG. Remission of severely impaired subjective wellbeing in 727 patients with schizophrenia treated with amisulpride. Acta Psychiatr Scand 2007;115:106–13.
   PubMed Web of Science ®Google Scholar
• Hedges LV, Hasselblad V. Meta-analysis of screening diagnostic tests. Psychol Bull 1995;117:167–78.
   Google Scholar
• Amelang M, Schmidt-Atzert L, Fydrich T. Psychologische Diagnostik und Intervention. Heidelberg: Springer Medizin Verlag (Reihe Springer-Lehrbuch); 2006.
   Google Scholar
• Flemenbaum A, Zimmermann RL. Inter- and intra-rater reliability of the Brief Psychiatric Rating Scale. Psychol Rep 1973;36:783–92.
   Google Scholar
• Hofer A, Hummer M, Huber R, Kurz M, Walch T, Fleischhacker WW. Selection bias in clinical trials with antripsychotics. J Clin Psychopharmacol 2000;20:699–702.
   PubMed Web of Science ®Google Scholar
• Cohen P, Cohen J. The clinician's illusion. Arch Gen Psychiatry 1984;41:1178–82
   PubMed Web of Science ®Google Scholar
• Höer A, Gothe H, Seidlitz C, Wittrup-Jensen K, Glaeske G. Prädiktoren für die Rehospitalisierung bei Patienten mit Schizophrenie. Nervenarzt 2006;77:S135.
   Google Scholar
• Karow A, Moritz S, Lambert M, Schoder S, Krausz M. PANSS syndromes and quality of life in schizophrenia. Psychopathology 2005;38:320–6.
   PubMed Web of Science ®Google Scholar